272 related articles for article (PubMed ID: 17519994)
21. Aspirin nonresponse in patients with arterial causes of ischemic stroke: considerations in detection and management.
Biller J
J Neurol Sci; 2008 Sep; 272(1-2):1-7. PubMed ID: 18534625
[TBL] [Abstract][Full Text] [Related]
22. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
Kirshner HS
J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
[TBL] [Abstract][Full Text] [Related]
23. The Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population.
Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici M; Mattle HP; Rothwell PM;
Cerebrovasc Dis; 2009; 27(6):608-13. PubMed ID: 19407444
[TBL] [Abstract][Full Text] [Related]
24. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma.
De Bruin ML; Dorresteijn LD; van't Veer MB; Krol AD; van der Pal HJ; Kappelle AC; Boogerd W; Aleman BM; van Leeuwen FE
J Natl Cancer Inst; 2009 Jul; 101(13):928-37. PubMed ID: 19535773
[TBL] [Abstract][Full Text] [Related]
26. Secondary prevention of ischaemic stroke and TIA.
Diener HC
Cardiovasc J Afr; 2008; 19(4):229. PubMed ID: 18776974
[No Abstract] [Full Text] [Related]
27. The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke.
Po HL; Lin YJ; Hseuh IH
Acta Neurol Taiwan; 2009 Jun; 18(2):98-103. PubMed ID: 19673361
[TBL] [Abstract][Full Text] [Related]
28. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
Weber R; Weimar C; Diener HC
Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
[TBL] [Abstract][Full Text] [Related]
29. [Transient ischemic attack, a medical emergency].
Uchiyama S
Brain Nerve; 2009 Sep; 61(9):1013-22. PubMed ID: 19803400
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
[TBL] [Abstract][Full Text] [Related]
31. Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients.
Georgiadis D; Arnold M; von Buedingen HC; Valko P; Sarikaya H; Rousson V; Mattle HP; Bousser MG; Baumgartner RW
Neurology; 2009 May; 72(21):1810-5. PubMed ID: 19321846
[TBL] [Abstract][Full Text] [Related]
32. Secondary prevention of stroke.
MacDougall NJ; Amarasinghe S; Muir KW
Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1103-15. PubMed ID: 19764863
[TBL] [Abstract][Full Text] [Related]
33. [Antiplatelet treatment for secondary prevention of ischemic stroke or transient ischemic attack].
Barinagarrementeria F; Arauz A; Ruiz-Sandoval JL; Cantú C; Leyva A; Murillo L; Villarreal J; Vargas RD; Alegría MA; Merino JG; Romano J;
Rev Invest Clin; 2010; 62(2):135-40. PubMed ID: 20597393
[No Abstract] [Full Text] [Related]
34. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
[TBL] [Abstract][Full Text] [Related]
35. Coronary risk stratification in patients with ischemic stroke or transient ischemic stroke attack.
Touzé E; Varenne O; Calvet D; Mas JL
Int J Stroke; 2007 Aug; 2(3):177-83. PubMed ID: 18705941
[TBL] [Abstract][Full Text] [Related]
36. Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style.
Fuentes B; Gállego J; Gil-Nuñez A; Morales A; Purroy F; Roquer J; Segura T; Tejada J; Lago A; Díez-Tejedor E; Alonso de Leciñana M; Alvarez-Sabin J; Arenillas J; Calleja S; Casado I; Castellanos M; Castillo J; Dávalos A; Díaz-Otero F; Egido JA; López-Fernández JC; Freijo M; García Pastor A; Gilo F; Irimia P; Maestre J; Masjuan J; Martí-Fábregas J; Martínez-Sánchez P; Martínez-Vila E; Molina C; Nombela F; Ribó M; Rodríguez-Yañez M; Rubio F; Serena J; Simal P; Vivancos J;
Neurologia; 2012; 27(9):560-74. PubMed ID: 21890241
[TBL] [Abstract][Full Text] [Related]
37. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
38. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack.
Schwamm LH; Fonarow GC; Reeves MJ; Pan W; Frankel MR; Smith EE; Ellrodt G; Cannon CP; Liang L; Peterson E; Labresh KA
Circulation; 2009 Jan; 119(1):107-15. PubMed ID: 19075103
[TBL] [Abstract][Full Text] [Related]
39. Hypertension and TIA.
Zhang WW; Cadilhac DA; Donnan GA; O'Callaghan C; Dewey HM
Int J Stroke; 2009 Jun; 4(3):206-14. PubMed ID: 19659823
[TBL] [Abstract][Full Text] [Related]
40. Statintherapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases.
Feher A; Pusch G; Koltai K; Tibold A; Gasztonyi B; Szapary L; Feher G
Int J Cardiol; 2011 Apr; 148(2):131-8. PubMed ID: 20843571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
